Hospital 9 de Julho pioneered the first PET-CT scan with FDOPA in Brazil for the evaluation of neurodegenerative diseases, such as Parkinson’s disease.
This advancement represents a milestone for nuclear medicine and neurology in the country.
FDOPA allows for a more precise evaluation of dopaminergic pathways, aiding in the investigation of movement disorders and offering a modern alternative to the older Trodat brain scintigraphy, now unavailable due to a lack of supplies.
In practice, this means greater diagnostic precision, more information for the physician, and…
–
Read More: https://tinyurl.com/Parkinsons-Health.
.
.
.
